(Bloomberg) -- Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, which could take place as soon as this year, according to people familiar with the matter.
The company is working with an adviser on seeking bank pitches for the share sale, said the people, who asked not to be identified as the information is private. A listing could happen in the second half of 2025 and value the Munich-based company at about €2 billion ($2.1 billion), the people said.
Deliberations are ongoing and details of the IPO including potential size and timeline could still change, the people said.
“Brainlab is keeping all options open in order to promote long-term growth and maximize shareholder value,” Brainlab said in a statement in response to a Bloomberg News query. “No decision on an IPO has been made and no mandate has been given to banks.”
Brainlab makes software for surgical and radiotherapy applications, serving 6,700 hospitals in 127 countries, according to its website. The company employs more than 2,400 people in 25 locations globally. Brainlab’s Snke OS, a proprietary operating system for health-care technologies, uses AI algorithms to catalog medical videos from microscopes or endoscopes and other cameras, its website shows.
Brainlab attempted but later halted its planned IPO in 2001 following the burst of the dot-com bubble. Its latest efforts to go public would ride on recent market enthusiasm for artificial intelligence-related industries.
Stefan Vilsmeier, Brainlab’s founder and chief executive officer, stepped down this month to become part of the board of directors, focusing on developing the firm’s health IT segment. Rainer Birkenbach, who had been the firm’s chief technology officer, took over as CEO.
©2025 Bloomberg L.P.